Close

First Installation of IMRISNV and IMRISneuro to be at New Smilow Cancer Hospital

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Dynacare, Evexia to Start Health Testing...

Dynacare, which happens to be one of the leading...

China Takes Decision on Medical Device...

China has hit back against certain EU restrictions that...

BD Commits Expanding the Prefilled Flush...

Beckton Dickinson – BD is investing over $35mn in...

MHRA Wants Fast Patient Access to...

The medicines and healthcare products regulatory agency – MHRA...

IMRIS Inc. announced the sale of IMRISNV to Connecticut-based Yale-New Haven Hospital, the primary teaching hospital for the Yale School of Medicine. With installation later this year, Yale-New Haven Hospital will become the first hospital in the world with IMRISNV’s unique capability of allowing both 3 Tesla MRI and bi-plane x-ray angiography in a single suite without the need to transport the patient between modalities. The IMRIS suite will be installed at the Hospital’s new Smilow Cancer Hospital building and will include an interventional theater for neurovascular procedures, an MR diagnostic center and an operating room for neurosurgery. Earlier in the year, Yale-New Haven purchased an IMRISneuro system which will be part of the fully integrated suite.

The IMRIS suite features a bi-plane angiography system in the interventional theater and a wide bore 3T MRI scanner. The MRI can be deployed into any of the three rooms, permitting rapid and efficient transitions between MR imaging and surgery or intervention without transporting the patient between modalities. MR images can be taken before and during procedures to assess tissue condition, and can also be used in conjunction with fluoroscopic images during neurovascular procedures. On completion, new images can be taken to evaluate the surgery or intervention.

Latest stories

Related stories

Dynacare, Evexia to Start Health Testing Services in Canada

Dynacare, which happens to be one of the leading...

China Takes Decision on Medical Device Contracts for the EU

China has hit back against certain EU restrictions that...

BD Commits Expanding the Prefilled Flush Syringes in the US

Beckton Dickinson – BD is investing over $35mn in...

MHRA Wants Fast Patient Access to Innovative Medical Devices

The medicines and healthcare products regulatory agency – MHRA...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back